Rob Krummen, Vektor Medical & Sascha Berger, TVM Capital Life Science- Studio Interview | LSI USA‘24

Rob Krummen and Sascha Berger joined us in the LSI Studio at LSI USA ‘24 in Dana Point, California.

Vektor Medical:
We are advancing care for arrhythmia patients by unlocking insights contained in a standard ECG. vMap is an AI-based arrhythmia analysis tool, created to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency.

Cardiac arrhythmias cause 10% of global deaths and over 25% of adults over 40 will develop a serious arrhythmia. Untreated arrhythmias not only raise the risk of death but are also associated with serious co-morbidities such as stroke and dementia.

TVM Capital Life Science:
Our mission is to invest in the development of exciting life science products and the growth of companies to become innovative leaders in their market segment. As true partners, we work closely with our portfolio companies, striving to enable their ideas and bring new therapies and medical products to market. Our track record of successful collaborations highlights our partnership and value-building approach.

Learn More:
https://www.vektormedical.com/
https://tvm-capital.com/

Our Next Event → LSI Europe ‘24 in Portugal on September 16th - 20th, 2024

Join us today → https://www.lsieuropesummit.com/

Follow us on social!
LinkedIn:   / life-science-intelligence  
Twitter:   / lsintelligence  
Instagram:   / lifescienceintelligence  
Facebook:   / lifescienceintelligence  

Subscribe to our YouTube:    / @lifescienceintelligence